Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 20 de 31
Filtrar
1.
BMC Public Health ; 21(1): 19, 2021 01 05.
Artigo em Inglês | MEDLINE | ID: mdl-33402150

RESUMO

BACKGROUND: Asthma control and monitoring still represents a challenge worldwide. Although the international guidelines suggest the interplay between secondary and primary care services as an effective strategy to control the disease, community pharmacies' are seldom involved in asthma control assessment. The present cross-sectional study aimed at providing a picture of the relationship between asthma severity and control in community pharmacies within the health district of the city of Verona (Veneto Region, North-Eastern Italy). METHODS: A call for participation was launched through the Pharmacists' Association of Verona. Patients referring to the participating pharmacies with an anti-asthmatic drug medical prescription and an asthma exemption code were asked to complete the Asthma Control Test (ACT) and a brief questionnaire collecting information on their age, sex, smoking status, aerobic physical exercise and usual asthma therapy, which also defined asthma severity. A multinomial logistic regression model was fitted to investigate the risk of uncontrolled as well as poorly controlled vs. controlled asthma (base). Results were expressed as relative risk ratios (RRR) with 95% confidence interval (95%CI). RESULTS: Fifty-seven community pharmacies accepted to participate and 584 asthmatic patients (54% females; mean-age: 51 ± 19 years) were consecutively recruited from 1st January to 30th June 2018 (6 months). Based upon ACT score 50.5% patients had a controlled asthma, 22.3% a poorly controlled and 27.2% uncontrolled. A variable proportion of patients with uncontrolled asthma were observed for every level of severity, although more frequently with mild persistent form of asthma. Most patients (92%) self-reported regular compliance with therapy. At multinomial regression analysis, patients under regular asthma treatment course (RRR = 0.33; 95%CI: 0.15; 0.77) were less likely to have an ACT< 16 compared to those not taking medications regularly. CONCLUSIONS: Overall, our findings highlighted an unsatisfactory asthma control in the general population, independently of the severity level of the disease. Community pharmacies could be a useful frontline interface between patients and the health care services, supporting an effective asthma management plan, from disease assessment and monitoring treatment compliance to referral of patients to specialist medical consultancies.


Assuntos
Asma , Serviços Comunitários de Farmácia , Farmácias , Adulto , Idoso , Asma/tratamento farmacológico , Estudos Transversais , Feminino , Humanos , Itália , Masculino , Pessoa de Meia-Idade , Farmacêuticos
2.
Expert Rev Clin Pharmacol ; 9(8): 1081-9, 2016 Aug.
Artigo em Inglês | MEDLINE | ID: mdl-27177184

RESUMO

INTRODUCTION: Allergic rhinitis (AR) affects 20-30% of women in reproductive age and may worsen during pregnancy. About 10% of the elderly suffer from AR, and it could be under-diagnosed in these patients. Many drugs are currently available, however AR treatment during pregnancy and old age represents a challenging issue. AREAS COVERED: A review of the literature on the topic has been performed. Expert commentary: In pregnancy, drug avoidance should be carefully balanced with the need for AR optimal control. Topical drugs are suggested as a first approach. The safety and tolerability profile of second-generation antihistamines is well supported. If allergen immunotherapy (AIT) is ongoing and well tolerated, there is no reason for stopping it. AIT initiation in pregnancy is not recommended. For elderly patients, no specific concerns have been highlighted regarding topical treatments, except from nasal decongestionants. Second generation antihistamines are generally well tolerated. Old age should not preclude AIT.


Assuntos
Antagonistas dos Receptores Histamínicos/administração & dosagem , Complicações na Gravidez/tratamento farmacológico , Rinite Alérgica/tratamento farmacológico , Administração Tópica , Idoso , Dessensibilização Imunológica/efeitos adversos , Dessensibilização Imunológica/métodos , Feminino , Antagonistas dos Receptores Histamínicos/efeitos adversos , Humanos , Descongestionantes Nasais/administração & dosagem , Gravidez , Complicações na Gravidez/imunologia , Rinite Alérgica/imunologia
4.
Eur Ann Allergy Clin Immunol ; 43(5): 135-40, 2011 Oct.
Artigo em Inglês | MEDLINE | ID: mdl-22145249

RESUMO

Allergen subcutaneous immunotherapy is a long lasting treatment which can modify the natural history of allergic respiratory diseases. Recommended administration is required for a minimum of three years. During this long term therapy the daily management is based on two crucial points, discussed in this review, such as the prevention and the treatment of side effects and the improvement and follow-up of patient adherence. This review specifically focuses on subcutaneous immunotherapy.


Assuntos
Dessensibilização Imunológica , Efeitos Colaterais e Reações Adversas Relacionados a Medicamentos , Hipersensibilidade Respiratória/tratamento farmacológico , Dessensibilização Imunológica/métodos , Dessensibilização Imunológica/tendências , Efeitos Colaterais e Reações Adversas Relacionados a Medicamentos/prevenção & controle , Humanos , Injeções Subcutâneas , Cooperação do Paciente , Guias de Prática Clínica como Assunto , Hipersensibilidade Respiratória/imunologia , Fatores de Tempo
5.
Eur Ann Allergy Clin Immunol ; 42(6): 216-20, 2010 Dec.
Artigo em Inglês | MEDLINE | ID: mdl-21287945

RESUMO

BACKGROUND: Non-steroidal anti-inflammatory drugs (NSAIDs) are a frequent cause of hypersensitivity reactions, therefore, in clinical practice, it's important to find safe and effective substances. OBJECTIVE: To evaluate the tolerability of etoricoxib and its subsequent actual use and safety at home. METHODS: Etoricoxib tolerance was assessed by single-blind-placebo-controlled oral challenges and its subsequent use was checked by a standardized telephone call. The test was performed in 139 subjects (83 single NSAID reactors and 56 multiple NSAID reactors). RESULTS: The drug was not tolerated in 4 cases (2.8%) causing wheals on the face area in 3 single reactors and a severe generalised reaction occurring three hours after the intake of a therapeutic dose in a multiple reactor. The phone calls showed that 64 (52.8%) patients did not take etoricoxib, mostly due to the fear of adverse effects; in 5 cases (4.2%), the practitioner prescribed a different NSAIDs. Only 52 (43%) subjects took etoricoxib after oral challenges; all tolerated the drug but 2 single reactors, who reported a very mild labial oedema. CONCLUSION: Our study confirmed the good long-term tolerability of etoricoxib in patients with a history of hypersensitivity to other NSAIDs without differences between single and multiple reactors. Nonetheless, in NSAID-intolerant subjects this drug should be first challenged in specialised centres due to the risk ofsevere reactions.


Assuntos
Anti-Inflamatórios não Esteroides/efeitos adversos , Inibidores de Ciclo-Oxigenase 2/efeitos adversos , Hipersensibilidade a Drogas/etiologia , Piridinas/efeitos adversos , Sulfonas/efeitos adversos , Adolescente , Adulto , Idoso , Etoricoxib , Feminino , Humanos , Masculino , Pessoa de Meia-Idade , Método Simples-Cego
6.
Allergy ; 64(9): 1379-82, 2009 Sep.
Artigo em Inglês | MEDLINE | ID: mdl-19627274

RESUMO

BACKGROUND: The preferential association of mastocytosis with hymenoptera sting reactions is well known, but there is no data on the prevalence of clonal mast cell disorders in subjects with severe systemic reactions due to foods or drugs. METHODS: Patients with food- or drug-induced severe systemic reactions, including anaphylaxis, and increased serum tryptase were studied for the presence of mastocytosis, and compared with a population of patients with hymenoptera allergy. The aetiological role of foods or drugs was assessed according to current recommendations. Systemic reactions were graded in severity according to the procedure described by Mueller. Serum tryptase was considered increased if the level was >11.4 ng/ml. Subjects with increased tryptase had dermatological evaluation and Bone marrow(BM) aspirate-biopsy, which included histology/cytology, flow cytometry and detection of KIT mutations. RESULTS: A total of 137 subjects (57 male, mean age 42 years) were studied. Of them, 86 proved positive for drugs and 51 for foods. Overall, out of 137 patients, only nine (6.6%) had a basal tryptase >11.4 ng/ml, and only two (1.5%) were diagnosed with mastocytosis. This was clearly different from patients with hymenoptera allergy, where 13.9% had elevated tryptase and 11.1% had a clonal mast cell disorder. CONCLUSION: The association of clonal mast cell disorders with hymenoptera allergy seems to be more specific than that with food- or drug-induced systemic reactions.


Assuntos
Venenos de Artrópodes/imunologia , Hipersensibilidade/epidemiologia , Mastocitose/epidemiologia , Adolescente , Adulto , Idoso , Animais , Criança , Pré-Escolar , Feminino , Humanos , Himenópteros/imunologia , Hipersensibilidade/imunologia , Masculino , Mastocitose/imunologia , Pessoa de Meia-Idade , Triptases/sangue , Adulto Jovem
9.
Allergy ; 62(5): 561-4, 2007 May.
Artigo em Inglês | MEDLINE | ID: mdl-17441797

RESUMO

BACKGROUND: Hymenoptera venom allergy can be effectively cured with specific immunotherapy, thus the correct identification of the allergen is essential. In the case of multiple skin and serum positivities it is important to know if a cross-reaction among venoms is present. We studied by CAP-inhibition assays the degree of cross-reactivity between Vespula vulgaris and Polistes dominulus. METHODS: Serum samples were obtained from consecutive patients with a clinical history of grade III-IV reactions to hymenoptera sting and with nondiscriminative skin/CAP positivity to both Vespula and Polistes. Inhibition assays were carried out with a CAP method, incubating the sera separately with both venoms and subsequently measuring the specific immunoglobulin E (IgE) to venoms themselves. RESULTS: Forty-five patients (33 male, mean age 40 years, age range 12-74, total serum IgE 242 +/- 168 kU/l) were included. Their specific IgE to Vespula and Polistes were 12.03 +/- 5.70 kU/l and 10.7 +/- 2.0 kU/l (P = NS), respectively. At the CAP-inhibition assays, in 25 patients a >75% heterologous inhibition by P. dominulus venom against V. vulgaris-specific IgE was found. In six subjects V. vulgaris venom effectively inhibited the P. dominulus-specific IgE. In the remaining 14 cases the CAP-inhibition test provided intermediate and not discriminative results. CONCLUSION: In 31/45 patients, the double sensitizations to venoms were probably the result of cross-reactions and the CAP-inhibition allowed identifying the true double sensitizations. This approach may be helpful for the correct prescription of immunotherapy in the case of V. vulgaris and P. dominulus double positivity.


Assuntos
Dessensibilização Imunológica , Hipersensibilidade/terapia , Imunoglobulina E/metabolismo , Venenos de Vespas/imunologia , Venenos de Vespas/metabolismo , Adolescente , Adulto , Idoso , Criança , Reações Cruzadas , Feminino , Humanos , Hipersensibilidade/imunologia , Masculino , Pessoa de Meia-Idade , Especificidade da Espécie , Venenos de Vespas/uso terapêutico
10.
Eur Ann Allergy Clin Immunol ; 36(6): 215-8, 2004 Jun.
Artigo em Inglês | MEDLINE | ID: mdl-15329003

RESUMO

BACKGROUND: Patients with aspirin-sensitive respiratory and cutaneous diseases experience cross reactions to all nonsteroidal anti-inflammatory drugs (NSAIDs) which inhibit cyclo-oxigenase (COX) enzymes. As are now available drugs which selectively inhibit COX-2, questions are raised whether cross-reactivity occurs between aspirin and these COX 2 inhibitors. OBJECTIVE: The aim of this study was to evaluate the tolerability of three COX-2 inhibitors (meloxicam, celecoxib and rofecoxib) in subjects with previous pseudoallergic respiratory and cutaneous reactions to NSAIDs. METHODS: 76 subjects with documented previous cutaneous and respiratory pseudoallergic reactions to aspirin and/or other NSAIDs underwent a single blind challenge with celecoxib, meloxicam and rofecoxib. RESULTS: All subjects with previous respiratory reactions tolerated all drugs. Three subjects with multiple-drug induced urticaria complained of a generalized reaction after challenge (Two due to celecoxib and one due to meloxicam). Among the group of patients with NSAIDs-induced urticaria five complained of a relapse of the disease due to rofecoxib (one subject), celecoxib (two subjects and meloxicam (two subjects). CONCLUSIONS: According to these results the cross-reactivity between aspirin and these COX-2 inhibitors does not occur in subjects with previous respiratory pseudoallergic reactions. A good safety profile was also demonstrated in patients with cutaneous reactions, being few reactions observed. However for this reason a controlled oral challenge with these drugs is useful for the proper management of patients sensitive to classic NSAIDs.


Assuntos
Anti-Inflamatórios não Esteroides/efeitos adversos , Inibidores de Ciclo-Oxigenase/efeitos adversos , Isoenzimas/antagonistas & inibidores , Lactonas/efeitos adversos , Sulfonamidas/efeitos adversos , Tiazinas/efeitos adversos , Tiazóis/efeitos adversos , Adolescente , Adulto , Idoso , Angioedema/induzido quimicamente , Aspirina/efeitos adversos , Asma/induzido quimicamente , Celecoxib , Reações Cruzadas , Ciclo-Oxigenase 2 , Inibidores de Ciclo-Oxigenase 2 , Hipersensibilidade a Drogas/etiologia , Feminino , Volume Expiratório Forçado/efeitos dos fármacos , Hemodinâmica/efeitos dos fármacos , Humanos , Masculino , Meloxicam , Proteínas de Membrana , Pessoa de Meia-Idade , Prostaglandina-Endoperóxido Sintases , Pirazóis , Recidiva , Rinite Alérgica Perene/induzido quimicamente , Método Simples-Cego , Sulfonas , Urticária/induzido quimicamente
11.
Artigo em Inglês | MEDLINE | ID: mdl-15301298

RESUMO

The nocebo effect is the onset of untoward reactions following the administration of an indifferent substance. The oral challenge with alternative drugs plays a central role in the management of drug allergy and the use of inert substances is part of this procedure. We evaluated the occurrence and clinical characteristics of nocebo effect in patients with adverse drug reactions. Six hundred patients, seen in three different centres (Genoa, Naples and Verona) with a history of reactions to drugs, underwent a blind oral challenge with the administration of an indifferent substance and active drugs. The administration of an inert substance provoked untoward reactions in 54 patients (27%) in Verona, 60 (30%) in Naples and 48 (24%) in Genoa. The overall occurrence of nocebo effect was 27%. The majority of reactions were subjective symptoms (itching, malaise, headache etc), perceived as troublesome by all subjects. The occurrence was significantly higher in women than in men. Our data, collected in a large population, confirm that the nocebo effect occurs frequently in clinical practice. In managing adverse drug reactions through oral challenge the nocebo effect is mandatory to recognize false positive responses.


Assuntos
Hipersensibilidade a Drogas/etiologia , Efeitos Colaterais e Reações Adversas Relacionados a Medicamentos , Adolescente , Adulto , Idoso , Criança , Feminino , Humanos , Masculino , Pessoa de Meia-Idade , Placebos
13.
G Ital Med Lav Ergon ; 25 Suppl(3): 192-3, 2003.
Artigo em Italiano | MEDLINE | ID: mdl-14979145

RESUMO

Reported cases of occupational asthma due to inhalation of milk proteins are rare. Our report is about the first evidence of occupational asthma in a health care worker, caused by an hidden exposure to casein, contained in a commercial dermatological powder widely used in geriatric patients treatment. The diagnosis is based on the case-history and on the positive skin prick test to a commercial and extemporary extract of the occupational allergen.


Assuntos
Asma/induzido quimicamente , Caseínas/toxicidade , Doenças Profissionais/induzido quimicamente , Adulto , Feminino , Humanos , Inalação
15.
Allergol Immunopathol (Madr) ; 30(4): 243-4, 2002.
Artigo em Inglês | MEDLINE | ID: mdl-12199970

RESUMO

Carrot is frequently involved in food allergies and oral allergy syndromes, usually in association with other foods. Nevertheless, carrot alone is rarely responsible for severe systemic reactions. We report a case of anaphylactic shock due to the inadvertent ingestion of carrot as a hidden allergen contained in an ice-cream. The etiological role of carrot in provoking the symptoms was thoroughly ascertained through appropriate in vivo and in vitro assays and by excluding, through double-blind placebo-controlled challenge, the involvement of other ingredients of the food. We highlight once again the harm and risks due to hidden food allergens contained in commercial preparations and the importance of thorough patient education and information.


Assuntos
Anafilaxia/etiologia , Daucus carota/efeitos adversos , Hipersensibilidade Alimentar/etiologia , Adulto , Método Duplo-Cego , Hipersensibilidade Alimentar/diagnóstico , Humanos , Sorvetes/análise , Masculino
16.
Allergol Immunopathol (Madr) ; 28(4): 238-42, 2000.
Artigo em Inglês | MEDLINE | ID: mdl-11022271

RESUMO

BACKGROUND: Efficacy and safety of local nasal immunotherapy has been demonstrated by many placebo-controlled clinical trials. The treatment schedule consists of an induction phase at increasing dosages followed by a maintenance phase. Aim of present study has been to evaluate a new simplified treatment schedule at constant dosage. METHODS AND RESULTS: 26 grass-allergic rhinitic patients have been treated according to the new constant dosage schedule, while 15 patients in a control group were treated with conventional incremental dosage schedule. A commercial preparation of allergens incorporated into powder (Allerkin). The total cumulative dosage administered with conventional schedule resulted higher than simplified constant schedule (5,025 vs 3,000 AU). To evaluate efficacy, symptom and rescue medication scores were recorded during the spring pollen season, and a subjective overall evaluation was asked to the patients at the end of the season. The analysis of scores showed that the two treatment schedules were equivalent as regards both efficacy and safety, being side effects light and restricted to the administration site (sneezing). CONCLUSIONS: The use of a constant dosage schedules is suggested for the administration of local nasal immunotherapy, having as advantage a better simplicity. Avoidance of mistakes in dosages is considered important in a therapy which is self-administered by patients.


Assuntos
Alérgenos/uso terapêutico , Dessensibilização Imunológica/métodos , Pólen/efeitos adversos , Rinite Alérgica Sazonal/terapia , Administração Intranasal , Adolescente , Adulto , Alérgenos/administração & dosagem , Esquema de Medicação , Feminino , Humanos , Insuflação , Masculino , Pessoa de Meia-Idade , Tamanho da Partícula , Projetos Piloto , Poaceae , Pós , Teste de Radioalergoadsorção , Rinite Alérgica Sazonal/etiologia , Rinite Alérgica Sazonal/imunologia , Segurança
17.
Artigo em Inglês | MEDLINE | ID: mdl-10780800

RESUMO

Despite the wide use of pine nuts, the fruit of Pinus pinea, only a few reports of allergic reactions to them have been published. We present herein a case of food allergy to pine nuts in a patient who showed no clinical symptoms to pine pollen despite the presence in her serum of specific IgE antibodies. In order to verify whether the reaction against pine nuts was IgE mediated, specific IgE against pine nuts and pollen were evaluated by skin-prick test, prick by prick and RAST. Immunoblotting and immunoblotting-inhibition were used to evaluate the allergenic components of both extracts and their cross-reactivity. Prick by prick with fresh pine nuts and RAST with pine nut and pine pollen extracts showed that the patient had high levels of specific IgE against both extracts. Immunoblotting experiments showed the presence in serum of IgE antibodies against several components in pine nuts and pollen. Immunoblotting-inhibition experiments demonstrated the presence of some cross-reacting components. These data confirm the existence of food allergy induced by pine nuts. This sensitization to pine nuts developed with no symptoms of pine pollinosis. Development of pollinosis may require a longer time of exposure to allergens. Based on the cross-reactivity between pine nut and pine pollen extracts, cosensitization to these two allergens could be possible.


Assuntos
Alérgenos/imunologia , Anafilaxia/etiologia , Hipersensibilidade Alimentar/etiologia , Frutas/imunologia , Proteínas de Plantas/imunologia , Pólen/imunologia , Árvores , Adulto , Angioedema/tratamento farmacológico , Angioedema/etiologia , Reações Cruzadas , Eletroforese em Gel de Poliacrilamida , Feminino , Humanos , Proteínas de Plantas/análise , Testes Cutâneos , Urticária/tratamento farmacológico , Urticária/etiologia
19.
Artigo em Inglês | MEDLINE | ID: mdl-10513355

RESUMO

Despite the large worldwide beer consumption, allergic reactions have very rarely been reported. We describe two cases of severe systemic reactions due to beer ingestion: one case of anaphylaxis requiring emergency care and one of generalized urticaria and angioedema. The two patients underwent a detailed diagnostic procedure involving skin testing, oral challenge with additives, detection of specific IgE to the components of beer, and oral challenge with beer in one patient. The results of the tests, in the particular skin tests and IgE assay, allowed us to detect barley as the specific ingredient responsible for the observed allergic reactions to beer. Therefore, such a sensitization should always be taken into account in the case of suspected reactions following beer ingestion.


Assuntos
Anafilaxia/etiologia , Cerveja/efeitos adversos , Hordeum/efeitos adversos , Adulto , Feminino , Humanos , Masculino , Testes Cutâneos
SELEÇÃO DE REFERÊNCIAS
DETALHE DA PESQUISA